Landoni F, Colombo A. Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update. J Gynecol Oncol. 2017;28:e34.
Article PubMed PubMed Central Google Scholar
Brooks RA, Wright JD, Powell MA, Rader JS, Gao F, Mutch DG, et al. Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. Gynecol Oncol. 2009;114:75–9.
Melamed A, Margul DJ. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018;379:1905–14.
Article PubMed PubMed Central Google Scholar
Levine MD, Brown J, Crane EK, Tait DL, Naumann RW. Outcomes of minimally invasive versus open radical hysterectomy for early stage cervical cancer incorporating 2018 FIGO staging. J Minim Invasive Gynecol. 2021;28:824–8.
Shah CA, Beck T. Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer. J Gynecol Oncol. 2017;28:e82.
Article PubMed PubMed Central Google Scholar
Kwon BS, Roh HJ, Lee S, Yang J, Song YJ, Lee SH, et al. Comparison of long-term survival of total abdominal radical hysterectomy and laparoscopy-assisted radical vaginal hysterectomy in patients with early cervical cancer: Korean multicenter, retrospective analysis. Gynecol Oncol. 2020;159:642–8.
Article PubMed CAS Google Scholar
Brandt B, Sioulas V, Basaran D, Kuhn T, LaVigne K, Gardner GJ, et al. Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: survival outcomes. Gynecol Oncol. 2020;156:591–7.
Article PubMed PubMed Central Google Scholar
Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895–904.
Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018;379:1905–14.
Article PubMed PubMed Central Google Scholar
Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.
Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1974;44:265–72.
Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–13.
Article PubMed CAS Google Scholar
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, et al. Cervical cancer, version 2.2015. J Natl Compr Canc Netw. 2015;13:395–404 quiz 404.
Article PubMed CAS Google Scholar
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, et al. Cervical cancer. J Natl Compr Canc Netw. 2013;11:320–43.
Article PubMed CAS Google Scholar
Huang H, Feng YL, Wan T, Zhang YN, Cao XP, Huang YW, et al. Effectiveness of sequential chemoradiation vs concurrent chemoradiation or radiation alone in adjuvant treatment after hysterectomy for cervical cancer: the STARS phase 3 randomized clinical trial. JAMA Oncol. 2021;7:361–9.
Small W Jr, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71:428–34.
Paik ES, Lim MC, Kim MH, Kim YH, Song ES, Seong SJ, et al. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028). Gynecol Oncol. 2019;154:547–53.
Kim SI, Kim TH, Lee M, Kim HS, Chung HH, Lee TS, et al. Impact of adjuvant radiotherapy on survival outcomes in intermediate-risk, early-stage cervical cancer: analyses regarding surgical approach of radical hysterectomy. J Clin Med. 2020;9(11):3545.
Article PubMed CAS PubMed Central Google Scholar
Nie JC, Wu QJ, Yan AQ, Wu ZY. Impact of different therapies on the survival of patients with stage I-IIA cervical cancer with intermediate risk factors. Ann Transl Med. 2021;9(2):142.
Article PubMed CAS PubMed Central Google Scholar
Gan YX, Du QH, Li J, Wei YP, Jiang XW, Xu XM, et al. Adjuvant radiotherapy after minimally invasive surgery in patients with stage IA1-IIA1 cervical cancer. Front Oncol. 2021;11:690777.
Article PubMed PubMed Central Google Scholar
Jhawar S, Hathout L, Elshaikh MA, Beriwal S, Small W Jr, Mahmoud O. Adjuvant chemoradiation therapy for cervical cancer and effect of timing and duration on treatment outcome. Int J Radiat Oncol Biol Phys. 2017;98:1132–41.
You KY, Zhou XH, Jiang YH, Bi ZF, Liu YM, Qiu XS. The selection of time interval between surgery and adjuvant therapy in early stage cervical cancer. Int J Gynecol Cancer. 2018;28:1325–32.
Article PubMed PubMed Central Google Scholar
Huang EY, Lin H, Wang CJ, Chanchien CC, Ou YC. Impact of treatment time-related factors on prognoses and radiation proctitis after definitive chemoradiotherapy for cervical cancer. Cancer Med. 2016;5:2205–12.
Article PubMed PubMed Central Google Scholar
Kim SW, Chun M, Ryu HS, Chang SJ, Kong TW, Oh YT, et al. Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy. BMC Cancer. 2017;17:297.
Article PubMed PubMed Central Google Scholar
DeBoer RJ, Umutoni V, Bazzett-Matabele L, Katznelson E, Nguyen C, Umwizerwa A, et al. Cervical cancer treatment in Rwanda: resource-driven adaptations, quality indicators, and patient outcomes. Gynecol Oncol. 2022;164:370–8.
Yamamoto T, Umezawa R, Tokunaga H, Kubozono M, Kozumi M, Takahashi N, et al. Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy. J Radiat Res. 2020;61:470–8.
Article PubMed PubMed Central Google Scholar
Chopra S, Gupta S, Kannan S, Dora T, Engineer R, Mangaj A, et al. Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial. J Clin Oncol. 2021;39:3682–92.
Article PubMed CAS Google Scholar
Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65:169–76.
Isohashi F, Mabuchi S, Yoshioka Y, Seo Y, Suzuki O, Tamari K, et al. Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters. Radiat Oncol. 2015;10:180.
Article PubMed PubMed Central Google Scholar
Hanprasertpong J, Jiamset I, Geater A, Leetanaporn K, Peerawong T. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer. J Gynecol Oncol. 2017;28(4):e42.
Article PubMed PubMed Central Google Scholar
Chen C, Fang Z, Wang Q, Li W, Li P, Wang L, et al. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma. Eur J Surg Oncol. 2021;47:346–52.
Di Donato V, Caruso G. Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review. J Gynecol Oncol. 2021;32(6):e83.
留言 (0)